214 related articles for article (PubMed ID: 26018083)
21. Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.
Clark K; Yau J; Bloom A; Wang J; Venzon DJ; Suzuki M; Pasquet L; Compton BJ; Cardell SL; Porcelli SA; Painter GF; Zajonc DM; Berzofsky JA; Terabe M
Front Immunol; 2019; 10():2355. PubMed ID: 31649670
[TBL] [Abstract][Full Text] [Related]
22. Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.
Schiefner A; Fujio M; Wu D; Wong CH; Wilson IA
J Mol Biol; 2009 Nov; 394(1):71-82. PubMed ID: 19732779
[TBL] [Abstract][Full Text] [Related]
23. Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d [corrected].
Muindi K; Cernadas M; Watts GF; Royle L; Neville DC; Dwek RA; Besra GS; Rudd PM; Butters TD; Brenner MB
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3052-7. PubMed ID: 20133624
[TBL] [Abstract][Full Text] [Related]
24. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
[TBL] [Abstract][Full Text] [Related]
25. Self-glycerophospholipids activate murine phospholipid-reactive T cells and inhibit iNKT cell activation by competing with ligands for CD1d loading.
Halder RC; Tran C; Prasad P; Wang J; Nallapothula D; Ishikawa T; Wang M; Zajonc DM; Singh RR
Eur J Immunol; 2019 Feb; 49(2):242-254. PubMed ID: 30508304
[TBL] [Abstract][Full Text] [Related]
26. The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode.
Li Y; Girardi E; Wang J; Yu ED; Painter GF; Kronenberg M; Zajonc DM
J Exp Med; 2010 Oct; 207(11):2383-93. PubMed ID: 20921281
[TBL] [Abstract][Full Text] [Related]
27. Fatty acid amide hydrolase shapes NKT cell responses by influencing the serum transport of lipid antigen in mice.
Freigang S; Zadorozhny V; McKinney MK; Krebs P; Herro R; Pawlak J; Kain L; Schrantz N; Masuda K; Liu Y; Savage PB; Bendelac A; Cravatt BF; Teyton L
J Clin Invest; 2010 Jun; 120(6):1873-84. PubMed ID: 20484813
[TBL] [Abstract][Full Text] [Related]
28. Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
Hung JT; Huang JR; Yu AL
J Biomed Sci; 2017 Mar; 24(1):22. PubMed ID: 28335781
[TBL] [Abstract][Full Text] [Related]
29. Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d.
Wu D; Zajonc DM; Fujio M; Sullivan BA; Kinjo Y; Kronenberg M; Wilson IA; Wong CH
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):3972-7. PubMed ID: 16537470
[TBL] [Abstract][Full Text] [Related]
30. Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs.
Tatituri RV; Watts GF; Bhowruth V; Barton N; Rothchild A; Hsu FF; Almeida CF; Cox LR; Eggeling L; Cardell S; Rossjohn J; Godfrey DI; Behar SM; Besra GS; Brenner MB; Brigl M
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1827-32. PubMed ID: 23307809
[TBL] [Abstract][Full Text] [Related]
31. Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation.
Im JS; Arora P; Bricard G; Molano A; Venkataswamy MM; Baine I; Jerud ES; Goldberg MF; Baena A; Yu KO; Ndonye RM; Howell AR; Yuan W; Cresswell P; Chang YT; Illarionov PA; Besra GS; Porcelli SA
Immunity; 2009 Jun; 30(6):888-98. PubMed ID: 19538930
[TBL] [Abstract][Full Text] [Related]
32. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
33. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor.
Zajonc DM; Cantu C; Mattner J; Zhou D; Savage PB; Bendelac A; Wilson IA; Teyton L
Nat Immunol; 2005 Aug; 6(8):810-8. PubMed ID: 16007091
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte.
Rhost S; Löfbom L; Rynmark BM; Pei B; Månsson JE; Teneberg S; Blomqvist M; Cardell SL
Eur J Immunol; 2012 Nov; 42(11):2851-60. PubMed ID: 22777932
[TBL] [Abstract][Full Text] [Related]
35. Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells.
Pei B; Vela JL; Zajonc D; Kronenberg M
Ann N Y Acad Sci; 2012 Apr; 1253(1):68-79. PubMed ID: 22352829
[TBL] [Abstract][Full Text] [Related]
36. CD1d-dependent expansion of NKT follicular helper cells in vivo and in vitro is a product of cellular proliferation and differentiation.
Rampuria P; Lang ML
Int Immunol; 2015 May; 27(5):253-63. PubMed ID: 25710490
[TBL] [Abstract][Full Text] [Related]
37. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
Gerth E; Mattner J
Front Immunol; 2019; 10():1449. PubMed ID: 31293596
[TBL] [Abstract][Full Text] [Related]
38. Acidification-dependent activation of CD1d-restricted natural killer T cells is intact in cystic fibrosis.
Rzemieniak SE; Hirschfeld AF; Victor RE; Chilvers MA; Zheng D; van den Elzen P; Turvey SE
Immunology; 2010 Jun; 130(2):288-95. PubMed ID: 20102408
[TBL] [Abstract][Full Text] [Related]
39. Glycolipids that elicit IFN-γ-biased responses from natural killer T cells.
Tyznik AJ; Farber E; Girardi E; Birkholz A; Li Y; Chitale S; So R; Arora P; Khurana A; Wang J; Porcelli SA; Zajonc DM; Kronenberg M; Howell AR
Chem Biol; 2011 Dec; 18(12):1620-30. PubMed ID: 22195564
[TBL] [Abstract][Full Text] [Related]
40. Application of natural killer T cells in antitumor immunotherapy.
Hong C; Park SH
Crit Rev Immunol; 2007; 27(6):511-25. PubMed ID: 18197797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
